ADMA Biologics, Inc. - יחס שווי חברה להכנסות ADMA

ADMA Biologics brings together highly qualified specialists within a strict FDA standards environment. The company implements advanced screening methods to create unique immunoglobulins. Patent advantages and raw material shortages allow it to maintain pricing power. The enterprise value-to-revenue multiple demonstrates the business valuation trend, where the 5851.45 indicator determines the metric value on this chart.
ADMA Bio - פילוחים אנליטיים ומדדי מפתח (ADMA)

When screening for issuer reliability, this metric allows for a business valuation by summing market capitalization with net debt and comparing the result to annual sales. By analyzing the EV-to-revenue ratio, an investor determines the fair value of the asset, noting that patent protection and strict FDA compliance in the production of immunoglobulins at ADMA Biologics (ADMA) create high barriers to entry for competitors.